Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Fareed Khawaja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Respiratory Tract Infections, Coronavirus Infections. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Cancer Center Support Grant.
Abstract (Originalsprache)
Background
Community respiratory viruses, such as seasonal human coronavirus (HCoV), commonly infect hematopoietic cell transplant (HCT) recipients. Recognizing the risk factors and outcomes of HCoV infections in HCT recipients is essential for the future development of potentially lifesaving therapeutics.
Methods
We performed a retrospective review of all HCoV‐infected HCT recipients from September 1, 2015 to August 31, 2017, at our institution. Patients were classified with upper respiratory tract infection (URI) or lower respiratory infection (LRI) based on predefined definitions for respiratory viral infections in HCT recipients. Patient data were collected to identify risk factors for HCoV LRI, and to calculate an immunodeficiency scoring index (ISI). Univariate and multivariate analysis were performed to identify risk factors for LRI.
Results
We identified 164 episodes in 138 HCT recipients (129 URI and 35 LRI) during the study period with an incidence of HCoV of 9%. Overall, 30‐day mortality was 17% and 0%, among patients with HCoV LRI or URI, respectively. On multivariate analysis, low‐albumin, coinfection with multiple respiratory viruses, and an ISI ≥ 5 were independent predictors of LRI and the latter was associated with increased risk of hospital admission, ICU admission, mechanical ventilation, and 30‐day mortality.
Conclusions
We identified unique characteristics that were associated with HCoV LRI in HCT recipients. An ISI ≥ 5 predicted HCoV LRI in HCT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Förderung
- NCI NIH HHS
- Cancer Center Support Grant
Zitieren
APA
Khawaja, F., Shigle, T. L., Yaghi, L., Daher, M., Ramdial, J. L., Ariza-Heredia, E., Jiang, Y., & Chemaly, R. F. (2025). Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.70094
Vancouver
Khawaja F, Shigle TL, Yaghi L, Daher M, Ramdial JL, Ariza-Heredia E, et al. Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients. Transplant Infectious Disease. 2025. doi:10.1111/tid.70094
BibTeX
@article{Khawaja2025,
author = {Khawaja, Fareed and Shigle, Terri Lynn and Yaghi, Layale and Daher, May and Ramdial, Jeremy L and Ariza-Heredia, Ella and Jiang, Ying and Chemaly, Roy F},
title = {Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.70094}
}
EUVIMED